Wang T, Wu G, Wang J, Cui Y, Ma J, Zhu Z et al (2020) Comparison of single-dose fosfomycin tromethamine and other antibiotics for lower uncomplicated urinary tract infection in women and asymptomatic bacteriuria in pregnant women: a systematic review and meta-analysis. Int J Antimicrob Agents 56(1):106018

Article  CAS  PubMed  Google Scholar 

Abou Heidar NF, Degheili JA, Yacoubian AA, Khauli RB (2019) Management of urinary tract infection in women: a practical approach for everyday practice. Urol Ann 11(4):339–346

Article  PubMed  PubMed Central  Google Scholar 

Jakobsen L, Lundberg CV, Frimodt-Møller N (2020) Ciprofloxacin pharmacokinetics/pharmacodynamics against susceptible and low-level resistant Escherichia coli isolates in an experimental ascending urinary tract infection model in mice. Antimicrob Agents Chemother 65(1):e01804–e01820

Article  PubMed  PubMed Central  Google Scholar 

Stapleton PJ, Lundon DJ, McWade R, Scanlon N, Hannan MM, O’Kelly F et al (2017) Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005–2014. Ir J Med Sci 186(3):733–741

Article  CAS  PubMed  Google Scholar 

Farfour E, Dortet L, Guillard T, Chatelain N, Poisson A, Mizrahi A et al (2022) Antimicrobial resistance in Enterobacterales recovered from urinary tract infections in France. Pathogens 11(3):356

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baran C, Küçükcan A (2022) Antimicrobial susceptibility of bacteria isolated from urine cultures in Southern Turkey. Curr Urol 16(3):180–184

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sugianli AK, Ginting F, Parwati I, de Jong MD, van Leth F, Schultsz C (2021) Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review. JAC Antimicrob Resist 3(1):dlab003

Article  PubMed  PubMed Central  Google Scholar 

Bullens M, de Cerqueira MA, Raziq S, Lee J, Khalid GG, Khan SN et al (2022) Antibiotic resistance in patients with urinary tract infections in Pakistan. Public Health Action 12(1):48–52

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ceran N, Mert D, Kocdogan FY, Erdem I, Adalati R, Ozyurek S et al (2010) A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections. J Infect Chemother 16(6):424–430

Article  CAS  PubMed  Google Scholar 

Ten Doesschate T, Kuiper S, van Nieuwkoop C, Hassing RJ, Ketels T, van Mens SP et al (2022) Fosfomycin vs ciprofloxacin as oral step-down treatment for Escherichia coli febrile urinary tract infections in women: a randomized, placebo-controlled, double-blind, multicenter trial. Clin Infect Dis 75(2):221–229

Article  PubMed  Google Scholar 

Hassan MM, Malik M, Saleem R, Saleem A, Zohaib K, Malik AY et al (2022) Efficacy of single dose of fosfomycin versus a five-day course of ciprofloxacin in patients with uncomplicated urinary tract infection. Cureus 14(5):e24843

PubMed  PubMed Central  Google Scholar 

Singh I, Murtaza S, Kaur I, Agrawal V (2019) Curative efficacy of fosfomycin tromethamine versus ciprofloxacin in the initial therapy of uncomplicated UTI—a prospective open-label randomised controlled clinical study. Indian J Surg [Internet]. [cited 2025 Mar 9]. Available from: https://www.semanticscholar.org/paper/Curative-Efficacy-of-Fosfomycin-Tromethamine-Versus-Singh-Murtaza/e1ef4498d12ab8964d004ef5e18be9d032a78b51

Cao D, Shen Y, Huang Y, Chen B, Chen Z, Ai J et al (2021) Levofloxacin versus ciprofloxacin in the treatment of urinary tract infections: evidence-based analysis. Front Pharmacol 12:658095

Article  CAS  PubMed  PubMed Central  Google Scholar 

Konwar M, Gogtay NJ, Ravi R, Thatte UM, Bose D (2022) Evaluation of efficacy and safety of fosfomycin versus nitrofurantoin for the treatment of uncomplicated lower urinary tract infection (UTI) in women—a systematic review and meta-analysis. J Chemother 34(3):139–148

Article  PubMed  Google Scholar 

Sharmin S, Kamal SMM, Reza MA, Elahi KMA, Elma SMM, Habib B (2022) Fosfomycin—a promising oral antibiotic for the treatment of urinary tract infection (UTI). OJU 12(05):257–270

Article  Google Scholar 

Kahlmeter G (2003) Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 22(Suppl 2):49–52

Article  PubMed  Google Scholar 

Zhanel GG, Walkty AJ, Karlowsky JA (2016) Fosfomycin: a first-line oral therapy for acute uncomplicated cystitis. Can J Infect Dis Med Microbiol 2016:2082693

Article  PubMed  PubMed Central  Google Scholar 

Zhanel GG, Zhanel MA, Karlowsky JA (2020) Oral and intravenous fosfomycin for the treatment of complicated urinary tract infections. Can J Infect Dis Med Microbiol 2020:8513405

Article  PubMed  PubMed Central  Google Scholar 

Abbott IJ, van Gorp E, van der Meijden A, Wijma RA, Meletiadis J, Roberts JA et al (2020) Oral fosfomycin treatment for enterococcal urinary tract infections in a dynamic in vitro model. Antimicrob Agents Chemother 64(6):e00342–e00420

Article  PubMed  PubMed Central  Google Scholar 

Cai T, Tamanini I, Tascini C, Köves B, Bonkat G, Gacci M et al (2020) Fosfomycin trometamol versus comparator antibiotics for the treatment of acute uncomplicated urinary tract infections in women: a systematic review and meta-analysis. J Urol 203(3):570–578

Article  PubMed  Google Scholar 

Falagas ME, Vouloumanou EK, Togias AG, Karadima M, Kapaskelis AM, Rafailidis PI et al (2010) Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 65(9):1862–1877

Article  CAS  PubMed  Google Scholar 

Alfaresi M, Hassan K, Alnjadat R (2019) Single-Dose Fosfomycin Trometamol Versus Other Antimicrobial Regimens For Treatment Of Uncomplicated Lower Urinary Tract Infection: A Systematic Review And Meta-Analysis. Open Microbiol J 13(1). https://doi.org/10.2174/1874285801913010193

Gutiérrez-Castrellón P, Díaz-García L, de Colsa-Ranero A, Cuevas-Alpuche J, Jiménez-Escobar I (2015) Efficacy and safety of ciprofloxacin treatment in urinary tract infections (UTIs) in adults: a systematic review with meta-analysis. Gac Med Mex 151(2):225–244

PubMed  Google Scholar 

Hadidi MF, Alhamami N, Alhakami M, Abdulhamid AS, Alsharif A, Alomari MS et al (2024) Antibiotics efficacy in clinical and microbiological cure of uncomplicated urinary tract infection: a systematic review and network meta-analysis. World J Urol 42(1):221

Article  PubMed  Google Scholar 

Tariq A, Shaikh SA, Tariq A, Anwar Z, Shahzad QUZ, Al-Shammari RF (2022) Treatment of acute, uncomplicated urinary tract infections in children: a comparison of a single oral dosage of fosfomycin against a seven-day course of ciprofloxacin. Pak J Med Health Sci 16(05):1575

Article  Google Scholar 

Iarikov D, Wassel R, Farley J, Nambiar S (2015) Adverse events associated with fosfomycin use: review of the literature and analyses of the FDA adverse event reporting system database. Infect Dis Ther 4(4):433–458

Article  PubMed  PubMed Central  Google Scholar 

Mayama T, Yokota M, Shimatani I, Ohyagi H (1993) Analysis of oral fosfomycin calcium (Fosmicin) side-effects after marketing. Int J Clin Pharmacol Ther Toxicol 31(2):77–82

CAS  PubMed  Google Scholar 

Anastasia A, Bonura S, Rubino R, Giammanco GM, Miccichè I, Di Pace MR et al (2023) The use of intravenous fosfomycin in clinical practice: a 5-year retrospective study in a Tertiary Hospital in Italy. Antibiotics (Basel) 12(6):971

Article  CAS  PubMed  Google Scholar 

Patel SS, Balfour JA, Bryson HM (1997) Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs 53(4):637–656

Article  CAS  PubMed  Google Scholar 

Chen TT, Chang YF, Wu YC (2023) Clinical use of intravenous fosfomycin in critical care patients in Taiwan. Pathogens 12(6):841

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duane S, Beecher C, Vellinga A, Murphy AW, Cormican M, Smyth A et al (2022) A systematic review of the outcomes reported in the treatment of uncomplicated urinary tract infection clinical trials. JAC Antimicrob Resist 4(2):dlac025

Article  PubMed  PubMed Central  Google Scholar 

Concia E, Bragantini D, Mazzaferri F (2017) Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections. J Chemother 29(sup1):19–28

Article  PubMed